Platform | Neovac

top of page

Scientists Collaborating

01

NeoVac's Platform

NeoVac has a broad portfolio of proprietary lipids advancing next-generation LNP technology to enable safer, adaptable mRNA therapeutics for vaccines, cancer immunotherapy, and autoimmune diseases

02

Tunable Degradability

Tailored cleavability of NeoVac’s lipids allows for improved safety and activity

Examining Blood Sample

bottom of page